JP2012516349A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012516349A5 JP2012516349A5 JP2011548297A JP2011548297A JP2012516349A5 JP 2012516349 A5 JP2012516349 A5 JP 2012516349A5 JP 2011548297 A JP2011548297 A JP 2011548297A JP 2011548297 A JP2011548297 A JP 2011548297A JP 2012516349 A5 JP2012516349 A5 JP 2012516349A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- haloalkyl
- halogen
- het
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(CC(C)(C)C1)*N(*C(C)(CCCCCCC2)CCCC2(C)S)*(*)CC(C)(C)N1C(c1ccc(C(N(*)*I)=O)nc1)=O Chemical compound CC(CC(C)(C)C1)*N(*C(C)(CCCCCCC2)CCCC2(C)S)*(*)CC(C)(C)N1C(c1ccc(C(N(*)*I)=O)nc1)=O 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N c1ccncc1 Chemical compound c1ccncc1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14798209P | 2009-01-28 | 2009-01-28 | |
| US61/147,982 | 2009-01-28 | ||
| PCT/US2010/022411 WO2010088392A1 (en) | 2009-01-28 | 2010-01-28 | Carboxamide compounds and methods for using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012516349A JP2012516349A (ja) | 2012-07-19 |
| JP2012516349A5 true JP2012516349A5 (https=) | 2013-03-14 |
| JP5658688B2 JP5658688B2 (ja) | 2015-01-28 |
Family
ID=42061132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011548297A Expired - Fee Related JP5658688B2 (ja) | 2009-01-28 | 2010-01-28 | カルボキサミド化合物およびその使用方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8362235B2 (https=) |
| EP (1) | EP2391616B1 (https=) |
| JP (1) | JP5658688B2 (https=) |
| KR (1) | KR101693061B1 (https=) |
| CN (1) | CN102365275B (https=) |
| AU (1) | AU2010208247B2 (https=) |
| BR (1) | BRPI1007287B8 (https=) |
| CA (1) | CA2750835C (https=) |
| EA (1) | EA022083B1 (https=) |
| ES (1) | ES2581678T3 (https=) |
| IL (1) | IL214203A (https=) |
| MX (1) | MX2011007639A (https=) |
| NZ (1) | NZ594556A (https=) |
| SG (1) | SG172974A1 (https=) |
| UA (1) | UA106600C2 (https=) |
| WO (1) | WO2010088392A1 (https=) |
| ZA (1) | ZA201105215B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0911681B8 (pt) * | 2008-04-23 | 2021-05-25 | Rigel Pharmaceuticals Inc | composto, composição farmacêutica, e, método para ativar a via de proteína quinase ativada por 5'-amp em uma célula in vitro |
| WO2011123681A1 (en) | 2010-03-31 | 2011-10-06 | Rigel Pharmaceuticals, Inc. | Methods for using carboxamide, sulfonamide and amine compounds |
| PE20130774A1 (es) * | 2010-07-29 | 2013-06-26 | Rigel Pharmaceuticals Inc | Compuestos heterociclicos activadores de ampk y metodos para emplearlos |
| US9005909B2 (en) | 2011-01-06 | 2015-04-14 | Rigel Pharmaceuticals, Inc. | Whole blood assay for measuring AMPK activation |
| US9409884B2 (en) | 2012-02-01 | 2016-08-09 | Rigel Pharmaceuticals, Inc. | 5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them |
| US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| EP2970177A1 (en) | 2013-03-15 | 2016-01-20 | Pfizer Inc. | Indole compounds that activate ampk |
| US20150087673A1 (en) * | 2013-09-26 | 2015-03-26 | Rigel Pharmaceuticals, Inc. | Methods for using and biomarkers for ampk-activating compounds |
| US20160214967A1 (en) | 2013-09-30 | 2016-07-28 | The University Of Tokyo | Activator of adiponectin receptor |
| JP7346425B2 (ja) | 2018-01-11 | 2023-09-19 | セントラス セラピューティクス | 疾患を治療するためのジヒドロセラミドデサチュラーゼ阻害剤 |
| US12194023B2 (en) | 2018-11-29 | 2025-01-14 | The Research Foundation For The State University Of New York | Compositions and methods for modular control of bioorthogonal ligation |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5889006A (en) * | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| KR100579792B1 (ko) * | 1998-05-13 | 2006-05-12 | 동화약품공업주식회사 | 신규 2,5-피리딘디카복실산 유도체 |
| US7109199B2 (en) * | 2000-09-22 | 2006-09-19 | Smithkline Beecham Corporation | Pyrazolopyridines and pyrazolopyridazines as antidiabetics |
| TW200503994A (en) * | 2003-01-24 | 2005-02-01 | Novartis Ag | Organic compounds |
| EP1965862A2 (en) * | 2005-12-21 | 2008-09-10 | Schering Corporation | Combination of an h3 antagonist/inverse agonist and an appetite suppressant |
| ATE507205T1 (de) | 2006-12-11 | 2011-05-15 | Genetics Co Inc | Aromatische 1,4-di-carboxylamide und deren verwendung |
| US8012955B2 (en) | 2006-12-28 | 2011-09-06 | Rigel Pharmaceuticals, Inc. | N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
| GB0706793D0 (en) * | 2007-04-05 | 2007-05-16 | Evotec Ag | Compounds |
| NZ585298A (en) | 2007-11-16 | 2012-08-31 | Rigel Pharmaceuticals Inc | Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| EP2231666B1 (en) * | 2007-12-12 | 2015-07-29 | Rigel Pharmaceuticals, Inc. | Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| BRPI0911681B8 (pt) * | 2008-04-23 | 2021-05-25 | Rigel Pharmaceuticals Inc | composto, composição farmacêutica, e, método para ativar a via de proteína quinase ativada por 5'-amp em uma célula in vitro |
| WO2011123681A1 (en) | 2010-03-31 | 2011-10-06 | Rigel Pharmaceuticals, Inc. | Methods for using carboxamide, sulfonamide and amine compounds |
-
2010
- 2010-01-28 MX MX2011007639A patent/MX2011007639A/es active IP Right Grant
- 2010-01-28 BR BRPI1007287A patent/BRPI1007287B8/pt not_active IP Right Cessation
- 2010-01-28 US US12/695,861 patent/US8362235B2/en not_active Expired - Fee Related
- 2010-01-28 JP JP2011548297A patent/JP5658688B2/ja not_active Expired - Fee Related
- 2010-01-28 SG SG2011050861A patent/SG172974A1/en unknown
- 2010-01-28 NZ NZ594556A patent/NZ594556A/xx not_active IP Right Cessation
- 2010-01-28 AU AU2010208247A patent/AU2010208247B2/en not_active Ceased
- 2010-01-28 EA EA201170979A patent/EA022083B1/ru not_active IP Right Cessation
- 2010-01-28 CN CN201080015415.6A patent/CN102365275B/zh not_active Expired - Fee Related
- 2010-01-28 CA CA2750835A patent/CA2750835C/en active Active
- 2010-01-28 KR KR1020117019811A patent/KR101693061B1/ko not_active Expired - Fee Related
- 2010-01-28 WO PCT/US2010/022411 patent/WO2010088392A1/en not_active Ceased
- 2010-01-28 ES ES10703206.2T patent/ES2581678T3/es active Active
- 2010-01-28 EP EP10703206.2A patent/EP2391616B1/en active Active
- 2010-01-28 UA UAA201110421A patent/UA106600C2/uk unknown
-
2011
- 2011-07-14 ZA ZA2011/05215A patent/ZA201105215B/en unknown
- 2011-07-20 IL IL214203A patent/IL214203A/en active IP Right Grant
-
2012
- 2012-12-27 US US13/728,374 patent/US8846600B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012516349A5 (https=) | ||
| JP2011503210A5 (https=) | ||
| JP2011506480A5 (https=) | ||
| ES2552733T3 (es) | Compuestos de carboxamida, sulfonamida y amina para trastornos metabólicos | |
| JP6388991B2 (ja) | キナーゼ阻害剤としてのアミノヘテロアリールベンズアミド | |
| ES2942319T3 (es) | Inhibidores de oxacina monoacilglicerol lipasa (MAGL) | |
| AU2017200745B2 (en) | Opioid receptor ligands and methods of using and making same | |
| JP2013532692A5 (https=) | ||
| EP3101015B1 (en) | Heterocyclic sulfonamide derivative and medicine comprising same | |
| JP2011527665A5 (https=) | ||
| NO20091681L (no) | Modulatorer av glukortikoidreseptoren, AP-1, og/eller NF-kappaB aktivitet og anvendelse derav | |
| JP2010514788A5 (https=) | ||
| TW202430504A (zh) | Ｋ他命的前藥及其組成物及用途 | |
| AU2012345746B2 (en) | Substituted anilines as CCR(4) antagonists | |
| TW201024313A (en) | Derivatives of 1-amino-2-cyclobutylethylboronic acid | |
| NO20091620L (no) | Boronsyre og estere som inhibitorer av fettsyreamidhydrolaser | |
| RU2011121567A (ru) | Изоиндолиновые соединения для применения при лечении рака | |
| JP2006513268A (ja) | ｍＧｌｕＲ１−およびｍＧｌｕＲ５−アンタゴニスト活性を有するベンゾアゾリルピペラジン誘導体 | |
| JP2011520832A5 (https=) | ||
| JP2013533229A5 (https=) | ||
| CN106714793B (zh) | 琥珀酸脱氢酶抑制剂(SDHi’s) | |
| JP7600134B2 (ja) | 機能性消化管障害及び口腔乾燥症の治療剤及び予防剤 | |
| ES2676396T3 (es) | Moduladores alostéricos positivos del receptor de acetilcolina nicotínico | |
| CN106699744B (zh) | 一种杂环类酰胺衍生物及其制备方法和在药学上的应用 | |
| WO2012146067A1 (zh) | 1，4-二氢吡啶-3，5-二羧酸酯衍生物及其制备与应用 |